Jamel A. Groves

Minipool testing for SARS‐CoV‐2 RNA in United States blood donors

D. Kessler, S. Kleinman, P. Saá, 2021, Transfusion.

Impact of one‐time testing for Trypanosoma cruzi antibodies among blood donors in the United States

B. Custer, M. Busch, G. Foster, 2019, Transfusion.

Recent and occult hepatitis B virus infections among blood donors in the United States

P. Saá, Y. Khudyakov, G. Xia, 2018, Transfusion.

Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021

B. Custer, B. Biggerstaff, P. Saá, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

How do we …form and coordinate a national serosurvey of SARS‐CoV‐2 within the blood collection industry?

P. Saá, J. Opsomer, R. Bruhn, 2022, Transfusion.

Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction

M. Busch, G. Simmons, S. Bakkour, 2022, Transfusion.

A probable case of West Nile virus transfusion transmission

S. Stramer, R. Dodd, J. Nomura, 2017, Transfusion.

Probable transfusion transmission of West Nile virus from an apheresis platelet that screened non‐reactive by individual donor‐nucleic acid testing

J. Fridey, Robert E Snyder, S. Stramer, 2020, Transfusion.

Powassan virus infection likely acquired through blood transfusion presenting as encephalitis in a kidney transplant recipient.

O. Kosoy, C. Gould, S. Basavaraju, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

West Nile virus activity in United States blood donors and optimizing detection strategies: 2014‐2018

G. Foster, S. Stramer, R. Dodd, 2019, Transfusion.